Dupilumab for Functional Impairment—Severe Asthma's Final Frontier

Research output: Contribution to journal › Editorial › Other › peer-review

Original language	English
Pages (from-to)	666-667
Number of pages	2
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	14
Issue number	3
DOIs	https://doi.org/10.1016/j.jaip.2026.01.010
Publication status	Published - Mar 2026

Access to Document

@article{ebded42ca5b34f53a897c6b319ecc4eb,

title = "Dupilumab for Functional Impairment—Severe Asthma's Final Frontier",

author = "Clark, \{Vanessa L.\} and Mark Hew",

year = "2026",

month = mar,

doi = "10.1016/j.jaip.2026.01.010",

language = "English",

volume = "14",

pages = "666--667",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "Elsevier BV",

number = "3",

}

TY - JOUR

T1 - Dupilumab for Functional Impairment—Severe Asthma's Final Frontier

AU - Clark, Vanessa L.

AU - Hew, Mark

PY - 2026/3

Y1 - 2026/3

UR - https://www.scopus.com/pages/publications/105031620872

U2 - 10.1016/j.jaip.2026.01.010

DO - 10.1016/j.jaip.2026.01.010

M3 - Editorial

C2 - 41786386

AN - SCOPUS:105031620872

SN - 2213-2198

VL - 14

SP - 666

EP - 667

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 3

ER -